An Irish-American biotechnology company, which is developing an anti-diarrhoea product, has secured €5 million in first-round funding.
Trimed is being backed by Dublin biotech fund Seroba Bioventures and Swiss venture capital company Inventages.
The company will be run as a joint venture between the Bray veterinary health firm Tridelta and the University of Nebraska.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team